The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

The University of Pittsburgh Medical Center (UPMC) indicated increased medical utilization and rising pharmacy costs as reasons for its $371 million operating loss for the first nine months of the ...

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a ...

Nearly half of individuals consuming alcohol at baseline reduced their alcohol consumption following the initiation of AOMs.

The drugs in question are known to scientists as GLP-1 agonists — so named because they imitate glucagon-like peptide-1, a ...

A new study suggests that popular weight loss drugs may reduce the risk of suicide in adolescents. KYW medical editor Dr. Brian McDonough has more.

New research reveals that popular diabetes and weight-loss drugs may also protect the kidneys. This groundbreaking study, ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

The medication’s primary mechanism involves mimicking glucagon-like peptide-1 (GLP-1), a naturally occurring hormone in the ...

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

Semaglutide, a GLP-1 agonist, has been widely studied due to its versatility, efficacy, and ability to address multiple ...

A SYSTEMATIC review investigating the impact of glucagon-like peptide-1 receptor agonists on alcohol consumption has yielded ...